Medicare Enrolled
Dr. Saba Bejanishvili, MD
Neurology · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bejanishvili from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bejanishvili?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bejanishvili
Dr. Saba Bejanishvili is a neurology specialist in Austell, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bejanishvili performed 1,641 Medicare services across 909 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bejanishvili received a total of $13,255 from 72 pharmaceutical and/or device companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bejanishvili is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 22% volume in GA
$13,255 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,641
Medicare services
Top 22% in GA for neurology
909
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
575 | $63 | $179 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
239 | $94 | $259 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
170 | $77 | $244 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
166 | $87 | $280 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
102 | $133 | $452 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 66 | $209 | $484 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
62 | $132 | $382 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
40 | $275 | $791 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
39 | $157 | $604 |
| New patient office visit, complex (60-74 min) | 39 | $160 | $480 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $104 | $337 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $117 | $366 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
27 | $40 | $90 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
17 | $267 | $794 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
16 | $231 | $786 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
12 | $200 | $679 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $60 | $199 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,255
Total received (2018-2024)
Avg $1,894/year across 7 years
Top 20% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
659
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,065 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$189 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,619
2023
$2,092
2022
$1,653
2021
$2,036
2020
$929
2019
$2,105
2018
$1,821
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$435
SK Life Science, Inc.
$159
JAZZ PHARMACEUTICALS INC.
$156
Lundbeck LLC
$151
ABBVIE INC.
$141
MDD US Operations, LLC
$136
Neurelis, Inc.
$118
Sumitomo Pharma America, Inc.
$118
ACADIA Pharmaceuticals Inc
$118
Eisai Inc.
$116
Mallinckrodt Hospital Products Inc.
$113
HARMONY BIOSCIENCES LLC
$106
Alexion Pharmaceuticals, Inc.
$81
Lilly USA, LLC
$71
ARGENX US, INC.
$67
Teva Pharmaceuticals USA, Inc.
$65
PFIZER INC.
$64
Kyowa Kirin, Inc.
$60
Biogen, Inc.
$59
Grifols USA, LLC
$57
Novartis Pharmaceuticals Corporation
$55
Supernus Pharmaceuticals, Inc.
$43
Neurocrine Biosciences, Inc.
$35
Averitas Pharma Inc.
$29
Inspire Medical Systems, Inc.
$29
Otsuka America Pharmaceutical, Inc.
$21
Amneal Pharmaceuticals LLC
$16
Top 3 companies account for 28.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,443
Greenwich Biosciences, Inc.
$587
Alexion Pharmaceuticals, Inc.
$555
Biogen, Inc.
$544
ACADIA Pharmaceuticals Inc
$530
Sunovion Pharmaceuticals Inc.
$507
Teva Pharmaceuticals USA, Inc.
$446
Lundbeck LLC
$436
Amgen Inc.
$412
Novartis Pharmaceuticals Corporation
$405
Sumitomo Pharma America, Inc.
$358
Lilly USA, LLC
$319
ABBVIE INC.
$316
JAZZ PHARMACEUTICALS INC.
$316
AbbVie Inc.
$313
Supernus Pharmaceuticals, Inc.
$302
SK Life Science, Inc.
$301
HARMONY BIOSCIENCES LLC
$289
EMD Serono, Inc.
$270
Eisai Inc.
$260
Kyowa Kirin, Inc.
$259
AstraZeneca Pharmaceuticals LP
$253
Neurelis, Inc.
$243
Biohaven Pharmaceuticals, Inc.
$220
Amneal Pharmaceuticals LLC
$208
Harmony Biosciences LLC
$205
Grifols USA, LLC
$185
Avanir Pharmaceuticals, Inc.
$165
Otsuka America Pharmaceutical, Inc.
$153
GENZYME CORPORATION
$152
PFIZER INC.
$149
MDD US Operations, LLC
$148
CSL Behring
$141
Mallinckrodt Hospital Products Inc.
$134
UPSHER-SMITH LABORATORIES LLC
$132
ARGENX US, INC.
$129
Neurocrine Biosciences, Inc.
$125
Janssen Pharmaceuticals, Inc
$82
Adamas Pharmaceuticals, Inc.
$82
Celgene Corporation
$73
Genentech USA, Inc.
$71
Upsher-Smith Laboratories LLC
$67
Allergan Inc.
$67
Biohaven Pharmaceutical Holding Company Ltd.
$63
Mallinckrodt LLC
$63
Jazz Pharmaceuticals Inc.
$63
AbbVie, Inc.
$59
PORTOLA PHARMACEUTICALS, INC.
$57
Impax Laboratories, Inc.
$55
Acorda Therapeutics, Inc
$46
SANOFI-AVENTIS U.S. LLC
$43
GE HEALTHCARE
$34
US WorldMeds, LLC
$34
Merz Pharmaceuticals, LLC
$30
Averitas Pharma Inc.
$29
Inspire Medical Systems, Inc.
$29
Vertical Pharmaceuticals, LLC
$29
Bausch Health US, LLC
$24
Mitsubishi Tanabe Pharma America, Inc.
$22
Mallinckrodt Enterprises LLC
$22
Banner Life Sciences, LLC
$22
Nuvectra Corporation
$20
IMPEL PHARMACEUTICALS INC.
$20
Mylan Pharmaceuticals Inc.
$19
AQUESTIVE THERAPEUTICS, INC.
$19
Bayer HealthCare Pharmaceuticals Inc.
$17
LivaNova USA, Inc.
$17
Horizon Therapeutics plc
$15
Zyla Life Sciences
$14
Almatica Pharma LLC
$14
Corium, LLC
$14
Allergan, Inc.
$12
Top 3 companies account for 19.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Algovita · Austedo XR · BAFIERTAM · BEVYXXA · BOTOX · BRILINTA · Betaseron · Briviact · COPAXONE · DUOPA · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Hizentra · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LUMIZYME · LYRICA · Leqembi · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONFI · OSMOLEX ER · OXTELLAR XR · Ongentys · PAXLOVID · PLEGRIDY · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qelbree · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · VascuClear · Vimpat · WAKIX · Wakix · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
207
Per 100K population
26.9
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bejanishvili is a clinical cardiology specialist, with above-average Medicare volume (top 22% in GA), with low-engagement industry engagement in the top 20% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bejanishvili experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bejanishvili performed 575 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bejanishvili receive payments from pharmaceutical companies?
Yes. Dr. Bejanishvili received a total of $13,255 from 72 companies across 659 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bejanishvili's costs compare to other neurologists in Austell?
Dr. Bejanishvili's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bejanishvili) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Austell
Browse neurologists in Austell ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Greenwich Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Greenwich Biosciences, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology